Cardiometabolic health benefits of dairy-milk polar lipids
| Autor: | Richard S Bruno, Avinash Pokala, Moises Torres-Gonzalez, Christopher N Blesso |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Nutrition Reviews |
| ISSN: | 1753-4887 0029-6643 |
| DOI: | 10.1093/nutrit/nuab085 |
| Popis: | Low-quality dietary patterns impair cardiometabolic health by increasing the risk of obesity-related disorders. Cardiometabolic risk relative to dairy-food consumption continues to be a controversial topic, due to recommendations that endorse low-fat and nonfat dairy foods over full-fat varieties despite accumulated evidence that does not strongly support these recommendations. Controlled human studies and mechanistic preclinical investigations support that full-fat dairy foods decrease cardiometabolic risk by promoting gut health, reducing inflammation, and managing dyslipidemia. These gut- and systemic-level cardiometabolic benefits are attributed, at least in part, to milk polar lipids (MPLs) derived from the phospholipid- and sphingolipid-rich milk fat globule membrane that is of higher abundance in full-fat dairy milk. The controversy surrounding full-fat dairy food consumption is discussed in this review relative to cardiometabolic health and MPL bioactivities that alleviate dyslipidemia, shift gut microbiota composition, and reduce inflammation. This summary, therefore, is expected to advance the understanding of full-fat dairy foods through their MPLs and the need for translational research to establish evidence-based dietary recommendations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|